$VRME
VerifyMe Inc Stock $vrme

$vrme Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121465924005643 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$5.759M	$8.713M	$25.31M
YoY Change	1.73%	-10.2%	29.31%
Cost Of Revenue	$3.499M	$5.576M	$16.31M
YoY Change	-10.44%	-18.93%	24.62%
Gross Profit	$2.260M	$3.137M	$9.003M
YoY Change	28.85%	11.04%	38.76%
Gross Profit Margin	39.24%	36.0%	35.57%
Selling, General & Admin	$1.509M	$2.984M	$12.22M
YoY Change	-53.57%	10.15%	20.48%
% of Gross Profit	66.77%	95.12%	135.78%
Research & Development	$55.00K	$84.00K	$107.0K
YoY Change	587.5%	425.0%	20.22%
% of Gross Profit	2.43%	2.68%	1.19%
Depreciation & Amortization	$299.0K	$294.0K	$1.134M
YoY Change	6.03%	10.53%	47.27%
% of Gross Profit	13.23%	9.37%	12.6%
Operating Expenses	$2.907M	$3.068M	$12.33M
YoY Change	-10.77%	12.59%	20.48%
Operating Profit	-$647.0K	$69.00K	-$3.328M
YoY Change	-56.98%	-31.0%	-11.18%
Interest Expense	-$38.00K	-$132.0K	-$261.0K
YoY Change	-49.33%	-2740.0%	-97.63%
% of Operating Profit		-191.3%
Other Income/Expense, Net	$94.00K	$65.00K	-$62.00K
YoY Change	-223.68%	2066.67%	-99.42%
Pretax Income	-$553.0K	$2.000K	-$3.389M
YoY Change	-65.0%	-98.15%	-76.47%
Income Tax
% Of Pretax Income
Net Earnings	-$553.0K	$2.000K	-$3.390M
YoY Change	-65.0%	-98.15%	-76.46%
Net Earnings / Revenue	-9.6%	0.02%	-13.39%
Basic Earnings Per Share	-$0.05		-$0.35
Diluted Earnings Per Share	-$0.05	$0.00	-$0.35
COMMON SHARES
Basic Shares Outstanding	10.14M shares	9.992M shares	9.766M shares
Diluted Shares Outstanding	10.07M shares		9.766M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.818M	$3.095M	$3.032M
YoY Change	-8.65%	-9.26%	-11.11%
Cash & Equivalents	$2.755M	$3.032M	$3.095M
Short-Term Investments
Other Short-Term Assets	$261.0K	$254.0K	$317.0K
YoY Change	-28.88%	-23.72%	-4.8%
Inventory	$32.00K	$38.00K	$38.00K
Prepaid Expenses
Receivables	$1.197M	$3.017M	$4.299M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.224M	$7.686M	$7.686M
YoY Change	-11.55%	-18.74%	-18.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$212.0K	$240.0K	$708.0K
YoY Change	-27.4%	-17.81%	-6.96%
Goodwill	$5.309M	$5.384M
YoY Change	283.88%	35.01%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$12.67M	$13.02M	$13.02M
YoY Change	-6.19%	15.27%	15.27%
TOTAL ASSETS
Total Short-Term Assets	$5.224M	$7.686M	$7.686M
Total Long-Term Assets	$12.67M	$13.02M	$13.02M
Total Assets	$17.89M	$20.71M	$20.71M
YoY Change	-7.82%	-0.23%	-0.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.214M	$3.310M	$3.310M
YoY Change	-23.07%	-15.39%	-15.39%
Accrued Expenses	$716.0K	$988.0K	$1.158M
YoY Change	-19.64%	9.53%	13.86%
Deferred Revenue
YoY Change
Short-Term Debt	$500.0K	$500.0K	$0.00
YoY Change	0.0%	0.0%
Long-Term Debt Due	$500.0K	$500.0K	$500.0K
YoY Change	-50.0%	0.0%	0.0%
Total Short-Term Liabilities	$2.792M	$5.141M	$5.141M
YoY Change	-26.7%	-5.3%	-5.3%
LONG-TERM LIABILITIES
Long-Term Debt	$1.850M	$1.975M	$1.975M
YoY Change	48.0%	43.64%	43.64%
Other Long-Term Liabilities	$860.0K	$1.058M	$1.058M
YoY Change	-38.13%	192.27%	192.27%
Total Long-Term Liabilities	$2.710M	$3.033M	$3.033M
YoY Change	2.65%	74.61%	74.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.792M	$5.141M	$5.141M
Total Long-Term Liabilities	$2.710M	$3.033M	$3.033M
Total Liabilities	$5.502M	$8.174M	$8.174M
YoY Change	-14.68%	14.07%	14.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$82.40M	-$81.85M
YoY Change	2.95%	4.32%
Common Stock	$10.00K	$10.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$589.0K	$659.0K
YoY Change	-25.73%	-30.56%
Treasury Stock Shares
Shareholders Equity	$12.39M	$12.53M	$12.53M
YoY Change
Total Liabilities & Shareholders Equity	$17.89M	$20.71M	$20.71M
YoY Change	-7.82%	-0.23%	-0.23%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$553.0K	$2.000K	-$3.390M
YoY Change	-65.0%	-98.15%	-76.46%
Depreciation, Depletion And Amortization	$299.0K	$294.0K	$1.134M
YoY Change	6.03%	10.53%	47.27%
Cash From Operating Activities	-$60.00K	$844.0K	$244.0K
YoY Change	-52.38%	621.37%	-109.56%
INVESTING ACTIVITIES
Capital Expenditures	$2.000K	$116.0K	$27.00K
YoY Change	-84.62%	0.0%
Acquisitions			$363.0K
YoY Change			-95.16%
Other Investing Activities	$0.00	$1.000K	-$429.0K
YoY Change	-100.0%	-104.76%	-94.36%
Cash From Investing Activities	-$110.0K	-$115.0K	-$1.195M
YoY Change	-82.29%	-16.06%	-84.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$106.0K	-646.0K	$634.0K
YoY Change	-125.06%	145.63%	-85.67%
NET CHANGE
Cash From Operating Activities	-$60.00K	844.0K	$244.0K
Cash From Investing Activities	-$110.0K	-115.0K	-$1.195M
Cash From Financing Activities	-$106.0K	-646.0K	$634.0K
Net Change In Cash	-$277.0K	83.00K	-$317.0K
YoY Change	-15.03%	-129.33%	-94.73%
FREE CASH FLOW
Cash From Operating Activities	-$60.00K	$844.0K	$244.0K
Capital Expenditures	$2.000K	$116.0K	$27.00K
Free Cash Flow	-$62.00K	$728.0K	$217.0K
YoY Change	-55.4%	72700.0%	-108.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001104038
CY2022Q4	vrme	Contingent Liabilitycurrent ContingentLiabilitycurrent		usd
CY2022Q4	vrme	Contingent Liability Noncurrent ContingentLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		usd
CY2022Q4	vrme	Convertible Note Related Party ConvertibleNoteRelatedParty		usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2022	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax		usd
CY2022	vrme	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2022	vrme	Impairments Impairments		usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized		usd
CY2023	vrme	Equity Received From Spac Equity Investment EquityReceivedFromSpacEquityInvestment		usd
CY2022	vrme	Leasehold Improvements LeaseholdImprovements		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023	vrme	Initial Recognition Of Rightofuse Asset And Lease Liability During Period InitialRecognitionOfRightofuseAssetAndLeaseLiabilityDuringPeriod		usd
CY2023	vrme	Treasury Stock Retired TreasuryStockRetired		usd
CY2023	vrme	Cancellation Of Common Stock CancellationOfCommonStock		usd
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet		usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign		usd
CY2022	vrme	Foreign Taxes And Rate Differential ForeignTaxesAndRateDifferential		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q4	vrme	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	11984934	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10144853	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	206
CY2023	dei	Auditor Name AuditorName	MaloneBailey, LLP
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3095000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3411000	usd
CY2023Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	165000	usd
CY2022Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	37000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3017000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4448000	usd
CY2023Q4	vrme	Unbilled Revenue UnbilledRevenue	1282000	usd
CY2022Q4	vrme	Unbilled Revenue UnbilledRevenue	1185000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	254000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	333000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	38000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	81000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	7686000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9458000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	240000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	292000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	468000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	469000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6927000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6545000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	5384000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	3988000	usd
CY2023Q4	us-gaap	Assets Assets	20705000	usd
CY2022Q4	us-gaap	Assets Assets	20752000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	500000	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	500000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3310000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3912000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	988000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	902000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	170000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115000	usd
CY2023Q4	vrme	Contingent Liabilitycurrent ContingentLiabilitycurrent	173000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5141000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5429000	usd
CY2023Q4	vrme	Contingent Liability Noncurrent ContingentLiabilityNoncurrent	751000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	307000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	875000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1375000	usd
CY2023Q4	vrme	Convertible Note Related Party ConvertibleNoteRelatedParty	475000	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	625000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	8174000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	7166000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10453315	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9341002	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10123964	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8951035	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	95031000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	92987000	usd
CY2023Q4	vrme	Treasury Stocks Share TreasuryStocksShare	329351	shares
CY2022Q4	vrme	Treasury Stocks Share TreasuryStocksShare	389967	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	659000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	949000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-81849000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78459000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	12531000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13586000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20705000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20752000	usd
CY2023	us-gaap	Revenues Revenues	25313000	usd
CY2022	us-gaap	Revenues Revenues	19576000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	16310000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	13088000	usd
CY2023	us-gaap	Gross Profit GrossProfit	9003000	usd
CY2022	us-gaap	Gross Profit GrossProfit	6488000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10586000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8428000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3328000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3747000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-161000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-88000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	12000	usd
CY2023	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	201000	usd
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-100000	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-10932000	usd
CY2023	us-gaap	Other Income OtherIncome	-2000	usd
CY2022	us-gaap	Other Income OtherIncome	31000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	326000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-62000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10651000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3390000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14398000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.70
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.70
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9766469	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8466075	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9766469	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8466075	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3390000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14398000	usd
CY2023	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap	7000	usd
CY2022	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap	-3000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	6000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3389000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14401000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3390000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14398000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	139000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	37000	usd
CY2023	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	200000	usd
CY2022	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	145000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-100000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-10932000	usd
CY2023	vrme	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	201000	usd
CY2023	vrme	Fair Value Of Restricted Stock Awards And Restricted Stock Units Issued In Exchange For Services FairValueOfRestrictedStockAwardsAndRestrictedStockUnitsIssuedInExchangeForServices	-1475000	usd
CY2022	vrme	Fair Value Of Restricted Stock Awards And Restricted Stock Units Issued In Exchange For Services FairValueOfRestrictedStockAwardsAndRestrictedStockUnitsIssuedInExchangeForServices	-1323000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2000	usd
CY2023	vrme	Impairments Impairments	190000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	12000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	326000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1134000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	770000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	25000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1295000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3352000	usd
CY2023	vrme	Oprating Unbilled Revenue OpratingUnbilledRevenue	-96000	usd
CY2022	vrme	Oprating Unbilled Revenue OpratingUnbilledRevenue	-1185000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	57000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-9000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	77000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-531000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3621000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	244000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2551000	usd
CY2022	vrme	Equity Received From Spac Equity Investment EquityReceivedFromSpacEquityInvestment	32000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	62000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	40000	usd
CY2023	vrme	Leasehold Improvements LeaseholdImprovements	8000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	363000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	7500000	usd
CY2023	vrme	Deferred Implementation Costs DeferredImplementationCosts	58000	usd
CY2022	vrme	Deferred Implementation Costs DeferredImplementationCosts	140000	usd
CY2023	us-gaap	Payments For Software PaymentsForSoftware	677000	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	236000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1195000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7884000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4528000	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1800000	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1100000	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	2000000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1000	usd
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	80000	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	102000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	36000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	34000	usd
CY2023	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	10000	usd
CY2022	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	291000	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	2300000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	1882000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	634000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4424000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-316000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-6011000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3411000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9422000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3095000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3411000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	165000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	33000	usd
CY2022	vrme	Initial Recognition Of Rightofuse Asset And Lease Liability During Period InitialRecognitionOfRightofuseAssetAndLeaseLiabilityDuringPeriod	552000	usd
CY2023	vrme	Noncash Change In Fair Value Of Interest Rate Swap NoncashChangeInFairValueOfInterestRateSwap	7000	usd
CY2022	vrme	Noncash Change In Fair Value Of Interest Rate Swap NoncashChangeInFairValueOfInterestRateSwap	-3000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	21167000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	205000	usd
CY2022	vrme	Restricted Stock Units Net Of Shares Withheld For Employee Tax RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax	1084000	usd
CY2022	vrme	Stock Purchase Plan1 StockPurchasePlan1	121000	usd
CY2022	vrme	Common Stock Issued In Relation To Stock Purchase Plan CommonStockIssuedInRelationToStockPurchasePlan	102000	usd
CY2022	vrme	Common Stock Issued In Relation To Private Placement CommonStockIssuedInRelationToPrivatePlacement	4528000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	96000	usd
CY2022	vrme	Common Stock Issued In Relation To Acquisition CommonStockIssuedInRelationToAcquisition	974000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	291000	usd
CY2022	vrme	Exercise Of Prefunded Warrants ExerciseOfPrefundedWarrants	1000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14398000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13586000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13586000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	468000	usd
CY2023	vrme	Restricted Stock Units Net Of Shares Withheld For Employee Tax RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax	970000	usd
CY2023	vrme	Common Stock Issued In Relation To Stock Purchase Plan CommonStockIssuedInRelationToStockPurchasePlan	134000	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	147000	usd
CY2023	vrme	Common Stock Issued In Relation To Acquisition CommonStockIssuedInRelationToAcquisition	625000	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3390000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	12531000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zUI4WNw2Q3w2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i><span style="text-decoration: underline"><span id="xdx_86B_zUFDhVhRinbb">Reclassifications</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Certain amounts presented for the year ended December 31, 2022, reflect reclassifications made to conform to the presentation in our current reporting period. These reclassifications had no effect on the previously reported net loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zX8tW1qKkiXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_866_zEt5c1721Jq9">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8286000	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3032000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3348000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	63000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	63000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3095000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3411000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	63000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	63000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	139000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	37000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	100000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	107000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	89000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized After Tax ForeignCurrencyTransactionGainLossUnrealizedAfterTax	5000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized After Tax ForeignCurrencyTransactionGainLossUnrealizedAfterTax	0	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	39000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	60000	usd
CY2023	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	100000	usd
CY2023Q4	vrme	Equity Investments Fair Value1 EquityInvestmentsFairValue1	0	usd
CY2022Q4	vrme	Equity Investments Fair Value1 EquityInvestmentsFairValue1	100000	usd
CY2023Q4	vrme	Equity Investments Fair Value1 EquityInvestmentsFairValue1	0	usd
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	10932000	usd
CY2023	us-gaap	Revenues Revenues	25313000	usd
CY2022	us-gaap	Revenues Revenues	19576000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1185000	usd
CY2023	vrme	Contract Asset Additions ContractAssetAdditions	3598000	usd
CY2022	vrme	Contract Asset Additions ContractAssetAdditions	2502000	usd
CY2023	vrme	Reclassification To Accounts Receivable Billed To Customers ReclassificationToAccountsReceivableBilledToCustomers	-3501000	usd
CY2022	vrme	Reclassification To Accounts Receivable Billed To Customers ReclassificationToAccountsReceivableBilledToCustomers	-1317000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1282000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1185000	usd
CY2023Q1	vrme	Business Combination Consideration Transferred BusinessCombinationConsiderationTransferred	360000	usd
CY2023Q1	vrme	Earnout Consideration EarnoutConsideration	1100000	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	314000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	173000	usd
CY2023Q1	vrme	Business Combination Long Term Contingent Consideration BusinessCombinationLongTermContingentConsideration	751000	usd
CY2022Q2	vrme	Business Combination Consideration Transferred BusinessCombinationConsiderationTransferred	7500000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6927000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	695000	usd
CY2022	vrme	Revenue1 Revenue1	25397000	usd
CY2022	vrme	Net Income Loss1 NetIncomeLoss1	-14298000	usd
CY2023	us-gaap	Acquisition Costs AcquisitionCosts	1383000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	13000	usd
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	5384000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	9006000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2079000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6927000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7613000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1068000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6545000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1030000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	657000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1134000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1109000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1105000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1070000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1814000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2612000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-14400000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-777000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3389000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14400000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-712000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3024000	usd
CY2023	vrme	Foreign Taxes And Rate Differential ForeignTaxesAndRateDifferential	-53000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	642000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1188000	usd
CY2023	vrme	Change In State Tax Rate ChangeInStateTaxRate	-25000	usd
CY2022	vrme	Change In State Tax Rate ChangeInStateTaxRate	-57000	usd
CY2023	vrme	Income Tax Reconciliation Prior Period True Up IncomeTaxReconciliationPriorPeriodTrueUp	267000	usd
CY2022	vrme	Income Tax Reconciliation Prior Period True Up IncomeTaxReconciliationPriorPeriodTrueUp	5045000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-119000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-776000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6318000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6495000	usd
CY2023Q4	vrme	Restricted Stock Rsas Rsus RestrictedStockRsasRsus	613000	usd
CY2022Q4	vrme	Restricted Stock Rsas Rsus RestrictedStockRsasRsus	503000	usd
CY2023Q4	vrme	Stock Options StockOptions	527000	usd
CY2022Q4	vrme	Stock Options StockOptions	562000	usd
CY2023Q4	vrme	Stock Purchase Plan Spp StockPurchasePlanSpp	2000	usd
CY2022Q4	vrme	Stock Purchase Plan Spp StockPurchasePlanSpp	8000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	45000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	71000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-27000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	22000	usd
CY2023Q4	vrme	Acquisition Transaction Costs AcquisitionTransactionCosts	172000	usd
CY2022Q4	vrme	Acquisition Transaction Costs AcquisitionTransactionCosts	110000	usd
CY2023Q4	vrme	Capitalized Research And Development CapitalizedResearchAndDevelopment	-1000	usd
CY2022Q4	vrme	Capitalized Research And Development CapitalizedResearchAndDevelopment	17000	usd
CY2023Q4	vrme	Unrealized Gain On Investment UnrealizedGainOnInvestment	2000	usd
CY2022Q4	vrme	Unrealized Gain On Investment UnrealizedGainOnInvestment	-1000	usd
CY2023Q4	vrme	Bad Debt BadDebt	42000	usd
CY2022Q4	vrme	Bad Debt BadDebt	9000	usd
CY2023Q4	vrme	Capital Loss Carryforward CapitalLossCarryforward	680000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	11000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1638000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1718000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3328000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3747000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-62000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10651000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3390000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14398000	usd
CY2022Q4	vrme	Dividend Income DividendIncome	-2000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8294000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7652000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8294000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7652000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	22700000	usd
CY2023	vrme	Description Of Ownership Change DescriptionOfOwnershipChange	Utilization of the net operating losses (NOL) carryforwards may be subject to a substantial annual limitation as required by Section 382 of the IRC, due to ownership change of the company that could occur in the future, as well as similar state provisions. In general, an “ownership change” as defined by Section 382 results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50 percentage points of the outstanding stock of a company by certain stockholders. These ownership changes may limit the amount of NOL carryforwards that can be utilized annually to offset future taxable income.
CY2023Q4	vrme	Deferred Tax Assets Valuation Allowance1 DeferredTaxAssetsValuationAllowance1	8300000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	2000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	500000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	875000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	500000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1400000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	1800000	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1800000	usd
CY2023	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	0	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1958000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.07602	pure
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	326000	usd
CY2023Q3	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	1100000	usd
CY2023Q3	vrme	Convertiable Promissory Notes Purchased By Related Party ConvertiablePromissoryNotesPurchasedByRelatedParty	475000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	31000	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	1100000	usd
CY2023	us-gaap	Restricted Stock Expense RestrictedStockExpense	477000	usd
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	239000	usd
CY2023	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	998000	usd
CY2022	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	1084000	usd
CY2023	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	5515	shares
CY2023	vrme	Share Forfeited Or Cancelled ShareForfeitedOrCancelled	1496	shares
CY2023	vrme	Nonqualified Stock Purchase Plan Expenses NonqualifiedStockPurchasePlanExpenses	53000	usd
CY2022	vrme	Nonqualified Stock Purchase Plan Expenses NonqualifiedStockPurchasePlanExpenses	122000	usd
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	80000	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	102000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	329351	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	389967	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	659000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	949000	usd
CY2020Q4	us-gaap	Accelerated Share Repurchases Adjustment To Recorded Amount AcceleratedShareRepurchasesAdjustmentToRecordedAmount	1500000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	6201	shares
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	10000	usd
CY2023	vrme	Share Repurchase Program Description ShareRepurchaseProgramDescription	In December 2023, the Company’s Board of Directors approved a new share repurchase program to allow the Company to spend up to $0.5 million to repurchase shares of its common stock so long as the price does not exceed $1.00 until December 14, 2024. During the year ended December 31, 2023, the Company did not repurchase shares of common stock under the Company’s current program.
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3779243	shares
CY2021Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	5.89
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	1590150	shares
CY2022	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice	3.22
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	265938	shares
CY2022	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice	19.21
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	5103455	shares
CY2022Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	4.34
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	474869	shares
CY2023	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice	6.34
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	4628586	shares
CY2023Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	4.13
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y3M18D
CY2023Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	4628586	shares
CY2023Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice	4.13
CY2023	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms	P2Y3M18D
CY2023	us-gaap	Profit Loss ProfitLoss	-3390000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-14398000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9766469	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8466075	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.70
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.70
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	137000	usd
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	103000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	182000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	85000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	28000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	18000	usd
CY2023	us-gaap	Lease Cost LeaseCost	210000	usd
CY2022	us-gaap	Lease Cost LeaseCost	103000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	468000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	469000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	170000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	307000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359000	usd
CY2023Q4	vrme	Total Operating Lease Liabilities TotalOperatingLeaseLiabilities	477000	usd
CY2022Q4	vrme	Total Operating Lease Liabilities TotalOperatingLeaseLiabilities	474000	usd
CY2023Q4	vrme	Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities	177000	usd
CY2022Q4	vrme	Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities	80000	usd
CY2022Q4	vrme	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities	552000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.064	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	191000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	195000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	139000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	45000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	570000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	93000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	477000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	170000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	307000	usd
CY2023Q4	us-gaap	Assets Assets	20705000	usd
CY2022Q4	us-gaap	Assets Assets	20752000	usd
CY2023	us-gaap	Revenues Revenues	25313000	usd
CY2022	us-gaap	Revenues Revenues	19576000	usd
CY2023	us-gaap	Gross Profit GrossProfit	9003000	usd
CY2022	us-gaap	Gross Profit GrossProfit	6488000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10586000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8428000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	107000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	89000	usd

Files In Submission

Name	View Source	Status
0001214659-24-005643-index-headers.html	Edgar Link	pending
0001214659-24-005643-index.html	Edgar Link	pending
0001214659-24-005643.txt	Edgar Link	pending
0001214659-24-005643-xbrl.zip	Edgar Link	pending
ex21_1.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex4_8.htm	Edgar Link	pending
ex97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vm12524110k.htm	Edgar Link	pending
vrme-20231231.xsd	Edgar Link	pending
vrme-20231231_def.xml	Edgar Link	unprocessable
vrme-20231231_lab.xml	Edgar Link	unprocessable
vrme-20231231_pre.xml	Edgar Link	unprocessable
vm12524110k_htm.xml	Edgar Link	completed
vrme-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRME
VerifyMe Inc Stock $vrme

2024 Q1 Form 10-K Financial Statement

#000121465924005643 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRME VerifyMe Inc Stock $vrme

2024 Q1 Form 10-K Financial Statement

#000121465924005643 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRME
VerifyMe Inc Stock $vrme